Chloe for COVID-19: Evolution of an Intelligent Conversational Agent to Address Infodemic Management Needs During the COVID-19 Pandemic.

COVID-19 artificial intelligence chatbot conversational agents digital health infodemic infodemiology misinformation public health virtual care

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
21 09 2021
Historique:
received: 20 01 2021
accepted: 10 07 2021
revised: 27 06 2021
pubmed: 11 8 2021
medline: 30 9 2021
entrez: 10 8 2021
Statut: epublish

Résumé

There is an unprecedented demand for infodemic management due to rapidly evolving information about the novel COVID-19 pandemic. This viewpoint paper details the evolution of a Canadian digital information tool, Chloe for COVID-19, based on incremental leveraging of artificial intelligence techniques. By providing an accessible summary of Chloe's development, we show how proactive cooperation between health, technology, and corporate sectors can lead to a rapidly scalable, safe, and secure virtual chatbot to assist public health efforts in keeping Canadians informed. We then highlight Chloe's strengths, the challenges we faced during the development process, and future directions for the role of chatbots in infodemic management. The information presented here may guide future collaborative efforts in health technology in order to enhance access to accurate and timely health information to the public.

Identifiants

pubmed: 34375299
pii: v23i9e27283
doi: 10.2196/27283
pmc: PMC8457340
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27283

Informations de copyright

©Sophia Siedlikowski, Louis-Philippe Noël, Stephanie Anne Moynihan, Marc Robin. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 21.09.2021.

Références

Digit Health. 2019 Aug 21;5:2055207619871808
pubmed: 31467682
NPJ Digit Med. 2020 May 4;3:65
pubmed: 32377576
Nature. 2021 Feb;590(7846):382-384
pubmed: 33594289
J Med Internet Res. 2020 Aug 7;22(8):e17158
pubmed: 32763886
J Med Internet Res. 2020 Jul 13;22(7):e16021
pubmed: 32673216

Auteurs

Sophia Siedlikowski (S)

Dialogue Health Technologies Inc, Montreal, QC, Canada.

Louis-Philippe Noël (LP)

Dialogue Health Technologies Inc, Montreal, QC, Canada.

Stephanie Anne Moynihan (SA)

Dialogue Health Technologies Inc, Montreal, QC, Canada.

Marc Robin (M)

Dialogue Health Technologies Inc, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH